| Anticancer potential of curcumin: preclinical and clinical studies BB Aggarwal, A Kumar, AC Bharti Anticancer research 23 (1/A), 363-398, 2003 | 3764 | 2003 |
| Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor–κB and IκBα kinase in human multiple myeloma cells, leading to suppression of … AC Bharti, N Donato, S Singh, BB Aggarwal Blood, The Journal of the American Society of Hematology 101 (3), 1053-1062, 2003 | 881 | 2003 |
| Nuclear factor-kappa B and cancer: its role in prevention and therapy AC Bharti, BB Aggarwal Biochemical pharmacology 64 (5-6), 883-888, 2002 | 754 | 2002 |
| Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells AC Bharti, N Donato, BB Aggarwal The journal of immunology 171 (7), 3863-3871, 2003 | 642 | 2003 |
| Nuclear factor–κB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis AC Bharti, S Shishodia, JM Reuben, D Weber, R Alexanian, ... Blood 103 (8), 3175-3184, 2004 | 421 | 2004 |
| Chronic diseases, inflammation, and spices: how are they linked? AB Kunnumakkara, BL Sailo, K Banik, C Harsha, S Prasad, SC Gupta, ... Journal of translational medicine 16, 1-25, 2018 | 366 | 2018 |
| Curcumin (diferuloylmethane) inhibits receptor activator of NF-κB ligand-induced NF-κB activation in osteoclast precursors and suppresses osteoclastogenesis AC Bharti, Y Takada, BB Aggarwal The journal of Immunology 172 (10), 5940-5947, 2004 | 338 | 2004 |
| Piceatannol inhibits TNF-induced NF-κB activation and NF-κB-mediated gene expression through suppression of IκBα kinase and p65 phosphorylation K Ashikawa, S Majumdar, S Banerjee, AC Bharti, S Shishodia, ... The Journal of Immunology 169 (11), 6490-6497, 2002 | 310 | 2002 |
| Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells S Mahata, AC Bharti, S Shukla, A Tyagi, SA Husain, BC Das Molecular cancer 10, 1-14, 2011 | 207 | 2011 |
| The role of TNF and its family members in inflammation and cancer: lessons from gene deletion BB Aggarwal, S Shishodia, K Ashikawa, AC Bharti Current Drug Targets-Inflammation & Allergy 1 (4), 327-341, 2002 | 194 | 2002 |
| Infection of human papillomaviruses in cancers of different human organ sites S Shukla, AC Bharti, S Mahata, S Hussain, R Kumar, S Hedau, BC Das Indian Journal of Medical Research 130 (3), 222-233, 2009 | 191 | 2009 |
| Differential expression and activation of NF‐κB family proteins during oral carcinogenesis: Role of high risk human papillomavirus infection A Mishra, AC Bharti, P Varghese, D Saluja, BC Das International journal of cancer 119 (12), 2840-2850, 2006 | 161 | 2006 |
| Anticancer property of Bryophyllum pinnata (Lam.) Oken. leaf on human cervical cancer cells S Mahata, S Maru, S Shukla, A Pandey, G Mugesh, BC Das, AC Bharti BMC complementary and alternative medicine 12, 1-11, 2012 | 157 | 2012 |
| Induction of cell cycle arrest and apoptosis by the proteasome inhibitor PS-341 in Hodgkin disease cell lines is independent of inhibitor of nuclear factor-κB mutations or … B Zheng, GV Georgakis, Y Li, A Bharti, D McConkey, BB Aggarwal, ... Clinical Cancer Research 10 (9), 3207-3215, 2004 | 145 | 2004 |
| Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection S Shukla, G Shishodia, S Mahata, S Hedau, A Pandey, S Bhambhani, ... Molecular cancer 9, 1-17, 2010 | 137 | 2010 |
| Chemopreventive agents induce suppression of nuclear factor‐κB leading to chemosensitization AC Bharti, BB Aggarwal Annals of the New York Academy of Sciences 973 (1), 392-395, 2002 | 136 | 2002 |
| Global proficiency study of human papillomavirus genotyping C Eklund, T Zhou, J Dillner Journal of clinical microbiology 48 (11), 4147-4155, 2010 | 132 | 2010 |
| Surface-engineered dendrimers for dual drug delivery: a receptor up-regulation and enhanced cancer targeting strategy RK Tekade, T Dutta, A Tyagi, AC Bharti, BC Das, NK Jain Journal of drug targeting 16 (10), 758-772, 2008 | 125 | 2008 |
| Folic acid and trastuzumab functionalized redox responsive polymersomes for intracellular doxorubicin delivery in breast cancer SV Lale, A Kumar, S Prasad, AC Bharti, V Koul Biomacromolecules 16 (6), 1736-1752, 2015 | 121 | 2015 |
| Evidence that receptor activator of nuclear factor (NF)-κB ligand can suppress cell proliferation and induce apoptosis through activation of a NF-κB-independent and TRAF6 … AC Bharti, Y Takada, S Shishodia, BB Aggarwal Journal of Biological Chemistry 279 (7), 6065-6076, 2004 | 121 | 2004 |
Ravi MehrotraFred Hutchinson Cancer Center/Univ. of Washington在 gov.in 的电子邮件经过验证
